Loading…
Mustang Bio, Inc. is projected to decline to $0.5445 by 2027, a -6% move from its current price of $0.5766. MBIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.5528 | $0.5761 | $0.6004 | -0.08% |
| Aug 6 | $0.543 | $0.5756 | $0.6102 | -0.17% |
| Aug 7 | $0.5355 | $0.5752 | $0.6178 | -0.25% |
| Aug 8 | $0.5292 | $0.5747 | $0.6241 | -0.33% |
| Aug 9 | $0.5236 | $0.5742 | $0.6297 | -0.41% |
| Aug 10 | $0.5186 | $0.5737 | $0.6348 | -0.50% |
| Aug 11 | $0.514 | $0.5733 | $0.6394 | -0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.514 | $0.5733 | $0.6394 | -0.58% |
| Week 2 | $0.4884 | $0.57 | $0.6651 | -1.15% |
| Week 3 | $0.469 | $0.5667 | $0.6846 | -1.72% |
| Week 4 | $0.4529 | $0.5634 | $0.7009 | -2.29% |
| Week 5 | $0.4388 | $0.5601 | $0.715 | -2.86% |
| Week 6 | $0.4262 | $0.5569 | $0.7277 | -3.42% |
| Week 7 | $0.4147 | $0.5537 | $0.7391 | -3.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trial for non-Hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, MB-101 and MB-108 as part of its program slate.
It has a license agreement with City of Hope National Medical Center and Nationwide Children’s Hospital.
Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Mustang Bio, Inc. trades under the MBIO ticker. The current price is $0.58 and the market cap is $4.39M, with a market ranking of 5323 within the exchange universe.
The near-term forecast shows a flat trajectory for 2026, with min $0.56, avg $0.58, max $0.7068 and ROI 0%, sentiment Neutral, suggesting limited movement around the current level in the early horizon.
Longer-range projections indicate mixed to bullish potential. In 2030 the avg is $0.5163 with a min of $0.3455 and a max of $0.8357 and ROI -11%, while 2032 shows a bullish inflection with avg $0.7356 and max $1.26 (ROI 26.8%). The forecast continues to 2040 with avg $0.9711 and max $1.93 (ROI 67.4%), and culminates in 2050 at avg $1.22 and max $2.73 (ROI 110.6%), signaling meaningful upside over the longer horizon.
A major floor 23.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 28.3% above — a clean break opens room to run.
A major ceiling 40.3% above — clearing it would confirm fresh momentum.
Key MBIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MBIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.587 | Sell | $0.5849 | Sell |
| MA 10 | $0.5926 | Sell | $0.5975 | Sell |
| MA 20 | $0.635 | Sell | $0.6228 | Sell |
| MA 50 | $0.6707 | Sell | $0.6665 | Sell |
| MA 100 | $0.7169 | Sell | $0.7481 | Sell |
| MA 200 | $0.9267 | Sell | $1.50 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.10 | Neutral |
| Stoch RSI (14) | 48.56 | Neutral |
| CCI (20) | -96.04 | Neutral |
| Williams %R (14) | -90.20 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -9.81 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 9.80 | Buy |
| TRIX (15) | -0.56 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 41.66 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.59 | Sell |
| ADX (14) | 15.83 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture remains Bearish with RSI(14) at 40.
The 50-day simple moving average sits at $0.6722 and the 200-day simple moving average at $0.9367, indicating a price below longer-term averages.
Support is at $0.56 and resistance at $0.74, with a 30-day price range of $0.4374 to $0.769. Annualized volatility is high at 80%, underscoring notable near-term risk and variability.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.56 | $0.5766 | $0.70 | 0% | Neutral | |
| $0.4143 | $0.5445 | $0.7676 | -6% | Neutral | |
| $0.3607 | $0.4961 | $0.7375 | -14% | Neutral | |
| $0.337 | $0.4814 | $0.7454 | -17% | Bearish | |
| $0.3519 | $0.52 | $0.8329 | -10% | Neutral | |
| $0.392 | $0.5975 | $0.9855 | +4% | Neutral | |
| $0.4656 | $0.7309 | $1.24 | +27% | Bullish | |
| $0.4308 | $0.6954 | $1.20 | +21% | Bullish | |
| $0.367 | $0.6085 | $1.08 | +6% | Neutral | |
| $0.4015 | $0.6832 | $1.23 | +18% | Neutral | |
| $0.5007 | $0.9616 | $1.88 | +67% | Bullish | |
| $0.5534 | $1.23 | $2.70 | +113% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.56 | $0.5766 | $0.7155 | +0.00% |
| September 2026 | $0.4798 | $0.5756 | $0.7159 | -0.16% |
| October 2026 | $0.4409 | $0.5347 | $0.6756 | -7.12% |
| November 2026 | $0.4298 | $0.5257 | $0.6729 | -1.67% |
| December 2026 | $0.4385 | $0.5406 | $0.70 | +2.84% |
Click any year to see its month-by-month MBIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Mustang Bio, Inc.'s 2026 outlook centres on $0.5766, within a $0.56 to $0.70 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MBIO could reach as high as $0.7676, with a base case around $0.5445 and support toward $0.4143 — roughly -6% from $0.5766. A consolidation phase looks the most probable path here.
Expect MBIO to range from $0.3607 to $0.7375 through 2028. The $0.4961 average target implies a -14% move from current prices. That is -9% versus the projected 2027 average. Price action looks broadly range-bound.
The MBIO price prediction for 2029 points to an average of $0.4814 (low $0.337, high $0.7454) — a potential decline of -17% on today's $0.5766. Expect choppier, lower action through this leg of the cycle.
In 2030, MBIO is projected to trade between $0.3519 and $0.8329, averaging $0.52 — a potential decline of -10% from today's $0.5766. That is up +8% on the projected 2029 average. Price action looks broadly range-bound.
Mustang Bio, Inc.'s 2031 outlook centres on $0.5975, within a $0.392 to $0.9855 range. That is up +15% on the projected 2030 average. That marks a +4% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, MBIO could reach as high as $1.24, with a base case around $0.7309 and support toward $0.4656 — roughly +27% from $0.5766. Momentum favours further upside here.
Expect MBIO to range from $0.4308 to $1.20 through 2033. The $0.6954 average target implies a +21% move from current prices. That is -5% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The MBIO price prediction for 2034 points to an average of $0.6085 (low $0.367, high $1.08) — a potential gain of +6% on today's $0.5766. Price action looks broadly range-bound.
In 2035, MBIO is projected to trade between $0.4015 and $1.23, averaging $0.6832 — a potential gain of +18% from today's $0.5766. That is up +12% on the projected 2034 average. A consolidation phase looks the most probable path here.
Mustang Bio, Inc.'s 2040 outlook centres on $0.9616, within a $0.5007 to $1.88 range. That is up +41% on the projected 2035 average. That marks a +67% change versus current levels. Momentum favours further upside here.
By 2050, MBIO could reach as high as $2.70, with a base case around $1.23 and support toward $0.5534 — roughly +113% from $0.5766. Buyers look set to stay in control over this stretch.
Investing $1,000 in MBIO today (≈ 1,734.304544 MBIO) could be worth
$2,132.64
+$1,132.64 (+113%) by 2050 · US Dollar
Based on the average projected MBIO price of $1.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MBIOwould be worth at today's price.
$1,000 invested in MBIO on Jul 31, 2025 (≈ 653.594783 MBIO) would be worth
$376.86
-$623.14 (-62.3%) today · 0.38× · US Dollar
Based on a MBIO entry price of $1.53 vs. today's $0.5766.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.562 | $1,025.98 | +2.6% |
| 1 month ago | $0.701 | $822.54 | -17.7% |
| 3 months ago | $0.754 | $764.72 | -23.5% |
| 6 months ago | $0.895 | $644.25 | -35.6% |
| 1 year ago | $1.53 | $376.86 | -62.3% |
| All time (5.0y) ago | $2,115 | $0.27 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MBIO forecast.
Our base-case forecast reaches $1.20 around 2050.
Implied market cap at $1.20: $8.08M
The multi-year outlook shows a path from modest near-term activity to notable longer-term upside. The 2030 average price is $0.5163 with ROI -11%, followed by 2032’s forecast of $0.7356 average and 26.8% ROI, suggesting a potential turning point toward stronger gains.
By 2040 the average price is projected at $0.9711 with a 67.4% ROI and a max of $1.93, and by 2050 the average reaches $1.22 with a 110.6% ROI and a max of $2.73, indicating substantial longer-term upside potential.
Sentiment shifts through the horizon, with Neutral in several years and Bullish signals emerging in 2032, 2040, and 2050, reflecting a balance of upside opportunities and downside risks. Investors should consider the risk of negative returns in multiple years (e.g., 2027, 2029, 2026) alongside the upside in later years, recognizing that these are forecasts and not guarantees.
Tap a question to reveal the answer.
The avg price in 2030 is $0.5163, with a min of $0.3455 and a max of $0.8357; ROI is -11% and sentiment is Neutral.
The forecast shows a mix of outcomes: near-term flatness in 2026 (avg $0.58, ROI 0%, Neutral) and negative ROI in some years such as 2029 (-17.7%), with potential positive upside in years like 2032 (avg $0.7356, ROI 26.8%) and beyond. This indicates uncertainty and risk alongside potential gains.
Yes. The forecast includes a 2032 max of $1.26, a 2040 max of $1.93, and a 2050 max of $2.73, indicating the possibility of surpassing $1 over longer horizons.
The 30-day range is $0.4374 to $0.769, current price is $0.58, RSI(14) is 40, and sentiment is BEARISH.
Market cap is $4.39M and rank is 5323; current price is $0.58.
Mustang Bio, Inc. Community Discussion
0Share your Mustang Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.